Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

By | July 18, 2022
A new study showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including SARS-CoV-2, in vivo.